← Back to Search

Behavioural Intervention

tDCS for Autism

N/A
Recruiting
Led By Peter Tsai, MD, PhD
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post treatment (approx at 3 month)
Awards & highlights

Summary

This trial looks at how electric current to the brain can help improve symptoms of Autism in children.

Who is the study for?
This trial is for children and young adults aged 5 to 21 with a clinical diagnosis of Autism Spectrum Disorder (ASD). It's not suitable for those who are pregnant, have brain implants or pacemakers, any metal implants, hearing or visual impairments, a history of brain injury, or known brain/skull abnormalities unrelated to ASD.
What is being tested?
The study is examining the impact of transcranial direct current stimulation (tDCS) on challenges associated with ASD. Participants will receive either the actual tDCS treatment or a sham (placebo-like) procedure to compare effects.
What are the potential side effects?
Potential side effects from tDCS may include discomfort at the electrode sites on the head, itching, tingling sensations during application, headache after treatment sessions, and fatigue.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post treatment (approx at 3 month)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post treatment (approx at 3 month) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Neurophysiological impacts as measured by Magnetoencephalography (MEG)
Neurophysiological impacts as measured by functional magnetic resonance imaging (fMRI)
Sensorimotor behavior as measured by Grip Strength
+4 more
Secondary study objectives
Executive functioning as measured by Dimensional Card Change Sort
Executive functioning as measured by Flanker Inhibitory Control and Attention
Working memory as measured by Stanford Binet-V Working Memory Subtest

Trial Design

2Treatment groups
Experimental Treatment
Group I: transcranial direct current stimulation (tDCS), then sham stimulationExperimental Treatment2 Interventions
Participants receives three weeks of 20-minute tDCS stimulation. After a washout period of 3 months, they then receive three weeks of sham stimulation
Group II: Sham stimulation, then transcranial direct current stimulation (tDCS)Experimental Treatment2 Interventions
Participants receives three weeks of sham stimulation. After a washout period of 3 months, they then receive three weeks of 20-minute tDCS stimulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sham
2013
Completed Phase 3
~2090

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,072 Previous Clinical Trials
1,056,202 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
60 Patients Enrolled for Autism Spectrum Disorder
Peter Tsai, MD, PhDPrincipal InvestigatorUT Southwestern Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
60 Patients Enrolled for Autism Spectrum Disorder
~22 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top